Abstract
Helicobacter pylori (H. pylori) infection is a common disease that can cause chronic gastritis, peptic ulcers, and gastric cancer. Nevertheless, due to its ability to elicit a systemic inflammatory response, it has also been related to several extra-gastric manifestations including endocrine disorders, such as autoimmune thyroid diseases, diabetes mellitus, dyslipidemia, and obesity. H. pylori infection has also been linked to osteoporosis, although currently available data are equivocal. This brief review will focus on the possible association between H. pylori infection and osteoporosis, a silent disease characterized by decreased bone mass that can increase the occurrence of fractures, disability, and mortality.
Similar content being viewed by others
References
Huang H, Tian J, Xu X, et al. A study on the roles of Helicobacter pylori in bile reflux gastritis and gastric cancer. J BUON. 2018;23:659–664.
Perri F, Clemente R, Festa V, et al. A Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies. Ital J Gastroenterol Hepatol. 1999;31:290–294.
Papamichael KX, Papaioannou G, Karga H, et al. Helicobacter pylori infection and endocrine disorders: Is there a link? World J Gastroenterol. 2009;15:2701–2707.
Sidlauskas KM, Sutton EE, Biddle MA. Osteoporosis in men: Epidemiology and treatment with denosumab. Clin Interv Aging. 2014;9:593–601.
Milte R, Crotty M. Musculoskeletal health, frailty and functional decline. Best Pract Res Clin Rheumatol. 2014;28:395–410.
Ferrari SL, Karasik D, Liu J, et al. Interactions of interleukin-6 promoter polymorphisms with dietary and lifestyle factors and their association with bone mass in men and women from the Framingham Osteoporosis Study. J Bone Miner Res. 2004;19:552–559.
Chung HW, Seo JS, Hur SE, et al. Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet. 2003;48:243–248.
Huang JV, Schooling CM. Inflammation and bone mineral density: A Mendelian randomization study. Sci Rep. 2017;7:8666.
Kakehasi AM, Rodrigues CB, Carvalho AV, et al. Chronic gastritis and bone mineral density in women. Dig Dis Sci. 2009;54:819–824.
Andersen BN, Johansen PB, Abrahamsen B. Proton pump inhibitors and osteoporosis. Curr Opin Rheumatol. 2016;28:420–425.
Figura N, Gennari L, Merlotti D, et al. Prevalence of Helicobacter pylori infection in male patients with osteoporosis and controls. Dig Dis Sci. 2005;50:847–852.
Kalantarhormozi MR, Assadi M, Vahdat K, et al. Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: A prospective cohort study. J Bone Miner Metab. 2016;34:422–428.
Kakehasi AM, Mendes CM, Coelho LG, et al. The presence of Helicobacter pylori in postmenopausal women is not a factor to the decrease of bone mineral density. Arq Gastroenterol. 2007;44:266–270.
Fotouk-Kiai M, Hoseini SR, Meftah N, et al. Relationship between Helicobacter pylori infection (Hp) and bone mineral density (BMD) in elderly people. Casp J Intern Med. 2015;6:62–66.
Chinda D, Shimoyama T, Iino C, et al. Decrease of estradiol and several lifestyle factors, but not Helicobacter pylori infection, are significant risks for osteopenia in Japanese females. Digestion. 2017;96:103–109.
Heidari B, Muhammadi A, Javadian Y, et al. Associated factors of bone mineral density and osteoporosis in elderly males. Int J Endocrinol Metab. 2017;15:e39662.
Lu LJ, Hao NB, Liu JJ, et al. Correlation between Helicobacter pylori infection and metabolic abnormality in general population: A cross-sectional study. Gastroenterol Res Pract. 2018;2018:7410801.
Asaoka D, Nagahara A, Hojo M, et al. The relationship between H. pylori infection and osteoporosis in Japan. Gastroenterol Res Pract. 2014;2014:340765.
Chung YH, Gwak JS, Hong SW, et al. Helicobacter pylori: A possible risk factor for bone health. Korean J Fam Med. 2015;36:239–244.
Chen LW, Chen FP, Hsieh CW, et al. Analysis of the associations among Helicobacter pylori infection, adiponectin, leptin, and 10-year fracture risk using the fracture risk assessment tool: A cross-sectional community-based study. PLoS ONE. 2017;12:e0175365.
Asaoka D, Nagahara A, Shimada Y, et al. Risk factors for osteoporosis in Japan: Is it associated with Helicobacter pylori? Ther Clin Risk Manag. 2015;11:381–391.
Mizuno S, Matsui D, Watanabe I, et al. Serologically determined gastric mucosal condition is a predictive factor for osteoporosis in Japanese men. Dig Dis Sci. 2015;60:2063–2069.
Lin SC, Koo M, Tsai KW. Association between Helicobacter pylori infection and risk of osteoporosis in elderly Taiwanese women with upper gastrointestinal diseases: A retrospective patient record review. Gastroenterol Res Pract. 2014;2014:814756.
Pan BL, Huang CF, Chuah SK, et al. Relationship between Helicobacter pylori infection and bone mineral density: A retrospective cross-sectional study. BMC Gastroenterol. 2018;18:54.
Chinda D, Shimoyama T, Sawada K, et al. Lifestyle factors rather than Helicobacter pylori infection or estradiol level are associated with osteopenia in Japanese men. Am J Mens Health. 2019;13:1557988319848219.
Shih HM, Hsu TY, Chen CY. Analysis of patients with Helicobacter pylori infection and the subsequent risk of developing osteoporosis after eradication therapy: A nationwide population-based cohort study. PLoS ONE. 2016;11:e0162645.
Moss S, Legon S, Davies J, Calam J. Cytokine gene expression in Helicobacter pylori associated antral gastritis. Gut. 1994;35:1567–1570.
Rokkas T, Pistiolas D, Sechopoulos P, et al. The long-term impact of Helicobacter pylori eradication on gastric histology: A systematic review and meta-analysis. Helicobacter. 2007;12:32–38.
Upala S, Sanguankeo A, Wijarnpreecha K, Jaruvongvanich V. Association between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. J Bone Miner Metab. 2016;34:482–483.
Wang T, Li X, Zhang Q, et al. Relationship between Helicobacter pylori infection and osteoporosis: A systematic review and meta-analysis. BMJ Open. 2019;9:e027356.
Bours SP, van Geel TA, Geusens PP, et al. Contributors to secondary osteoporosis and metabolic bone diseases in patients presenting with a clinical fracture. J Clin Endocrinol Metab. 2011;96:1360–1367.
Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am J Obstet Gynecol. 2006;194:S3–S11.
Author information
Authors and Affiliations
Contributions
K.P. and G.P. wrote the manuscript; A.S.C. and M.A.C. critically revised the manuscript. All the authors reviewed and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
A.S.C has received consulting fees from Abbvie, Janssen, Takeda Pfizer, Amag, and Arena and research support from Miraca. K.P. has received a lecture fee from Mitsubishi Tanabe Pharma. The remaining authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Papamichael, K., Papaioannou, G., Cheifetz, M.A. et al. Bone of Contention: Helicobacter pylori and Osteoporosis—Is There an Association?. Dig Dis Sci 64, 2736–2739 (2019). https://doi.org/10.1007/s10620-019-05775-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-019-05775-4